Skip to content

The Evaluation of Infant Formulas Fed to Infants With Common Feeding Problems

The Evaluation of Infant Formulas Fed to Infants With Common Feeding Problems

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01934257
Enrollment
296
Registered
2013-09-04
Start date
1994-06-30
Completion date
1996-06-30
Last updated
2013-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Common Infant Feeding Problems

Brief summary

This clinical trial will determine if the formula given to infants experiencing fussiness, crying, cramping, gas, and/or diarrhea, is accepted and well tolerated and helps to resolve symptoms.

Interventions

OTHERMarketed milk-based lactose-containing infant formula
OTHERMarketed milk-based lactose-free infant formula
OTHERMarketed soy-based lactose-free infant formula

Sponsors

Mead Johnson Nutrition
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
2 Weeks to 12 Weeks
Healthy volunteers
No

Inclusion criteria

* Subject is between 2 and 12 weeks of age * Subject has currently been receiving a milk-based lactose-containing formula for at least 5 days as the sole item of diet * Subject has never switched to any lactose free formula * The parent/guardian who will fill out the quality of life questionnaire is female and at least 18 years of age * The parent/guardian has reported an unsolicited history of feeding problems including fussiness/crying/cramping, gas, or diarrhea * Signed Informed Consent

Exclusion criteria

* Subject is in daycare for more than 4 hours per day (20 hours per week) * Subject has serious perinatal complications, underlying disease or congenital malformations that impair normal formula feeding * The parent/guardian who will fill out the quality of life questionnaire has chronic illness, e.g. diabetes, inflammatory bowel disease or other illness requiring daily medication or treatment * Subject has acute infectious diarrhea or any other intercurrent illness

Design outcomes

Primary

MeasureTime frame
Early Infant Temperament Questionnaire14 days

Secondary

MeasureTime frame
Infant Characteristic Questionnaire14 days
Maternal Efficacy Questionnaire14 days
Mental Health Inventory Questionnaire14 days

Countries

Canada, United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026